Farrell Michael J. 4

What Happened

• Michael J. Farrell, a Zimmer Biomet (ZBH) director, was credited with 420.97 phantom stock units on 2026-03-31 as an award under the Zimmer Biomet Deferred Compensation Plan for Non‑Employee Directors. The units were recorded at $0.00 (no cash purchase) and are a derivative award rather than issued common stock. The grant includes 48.381 phantom units accrued on Jan 30, 2026 under the plan’s dividend reinvestment provision.

Key Details

• Transaction date and price: 2026-03-31; 420.97 units @ $0.00 (award).
• Conversion/exercise: 1-for-1 (units track one share each for value purposes).
• Settlement: Units are to be settled in cash in a lump sum within 60 days after cessation of the reporting person’s service as a director.
• Shares/units owned after transaction: Not specified in this filing.
• Footnotes: Units accrued under the non‑employee director deferred compensation plan; includes dividend‑reinvestment accrual of 48.381 units.
• Filing timeliness: Report filed 2026-04-02 for a 2026-03-31 report date; no late‑filing flag indicated.

Context

• These are phantom (deferred compensation) units, not immediate common shares. They represent a future cash payout tied to the company’s stock (1-for-1), typically a routine form of director compensation and not a direct buy/sell signal about the insider’s view of the stock.